Metraipolis › archive › dc_146542016f96

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis — Europe PMC PMID:41570068

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41570068
DOI
10.1073/pnas.2532212123
License (as archived)
solo-consultazione
Archived
2026-11-06T13:52:10.216Z
SHA-256 of the archived text
cf7e2a76fcc1e6c66fa809424008a09cd568402c1a3bd8bdcd91548da19d8fac
Stable URL of this page
https://metraipolis.com/documento/dc_146542016f96

How to cite

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis — Europe PMC PMID:41570068 — Europe PMC (en), https://europepmc.org/article/MED/41570068 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_146542016f96 (Metraipolis archive dc_146542016f96, sha256 cf7e2a76fcc1e6c66fa809424008a09cd568402c1a3bd8bdcd91548da19d8fac)
BibTeX
@misc{dc146542016f96,
  title = {Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis — Europe PMC PMID:41570068},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41570068},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_146542016f96; sha256 cf7e2a76fcc1e6c66fa809424008a09cd568402c1a3bd8bdcd91548da19d8fac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41570068. Agents can read the archived copy with the MCP tool read_document.